Trabecular meshwork/Schlemm's canal-based procedures are generally among the safest
MIGS, with mostly self-limited and nonvision-threatening complications. Subconjunctival gel …

Purpose To assess the 3‐year effectiveness and safety of the XEN gel stent implanted ab
interno in open‐angle glaucoma (OAG). Methods This study was a multicentre, retrospective …

Methods: This was a prospective, interventional study, conducted at a single tertiary
glaucoma center. Fifty-one eyes of 51 patients with raised IOP associated with either a …

Purpose The aim of this study was to evaluate the efficacy of XEN® Gel Stent implantation in
the treatment of primary open‐angle glaucoma (POAG) and pseudoexfoliation glaucoma …

Background Long-term safety profile and efficacy in relation to the so-called microinvasive
glaucoma surgery (MIGS) techniques are still under evaluation. The XEN45® gel stent …

Purpose To report the long-time success rate of XEN 45 gel stent implantation in a
Scandinavian population. Patients and Methods This was a retrospective single-center …

Biomaterials are implanted in millions of individuals worldwide each year. Both naturally
derived and synthetic biomaterials induce a foreign body reaction that often culminates in …

Abstract The XEN Gel Stent (Allergan Inc., an Abbvie company) is an implant that lowers
intraocular pressure by creating a filtration pathway from the anterior chamber to the …

Purpose To compare clinical outcomes following gel stent implantation via ab externo and
ab interno approaches in patients with refractory glaucoma. Patients and Methods This …

Purpose Evaluation of 1-year-outcome of XEN 45 gel stent surgery in a Swedish cohort with
regard to clinical success, complications, and learning curve. Patients and Methods This …